[an error occurred while processing this directive]
中华放射肿瘤学杂志
   2025年4月8日 星期二     首 页 |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告合作  |  学术影响  |  收录情况  |  联系我们  |  English
中华放射肿瘤学杂志  2018, Vol. 27 Issue (9): 793-797    DOI: 10.3760/cma.j.issn.1004-4221.2018.09.001
头颈部肿瘤 最新目录| 下期目录| 过刊浏览| 高级检索 [an error occurred while processing this directive]|[an error occurred while processing this directive]
CT引导下125I粒子植入治疗放疗后复发头颈部肿瘤的临床效果
吉喆, 姜玉良, 郭福新, 彭冉, 徐飞, 孙海涛, 范京红, 李卫燕, 王俊杰
100191 北京大学第三医院肿瘤放疗科
Clinical efficacy of CT-guided iodine-125 seed implantation for recurrent head and neck carcinoma after external beam radiotherapy
Ji Zhe, Jiang Yuliang, Guo Fuxin, Peng Ran, Xu Fei, Sun Haitao, Fan Jinghong, Li Weiyan, Wang Junjie
Department of Radiation Oncology,Peking University Third Hospital,Beijing 100191,China
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      背景资料
摘要 目的 分析125I粒子植入治疗放疗后复发头颈部肿瘤的疗效及安全性。方法 纳入自2007-2015年于我科接受CT引导下125I粒子植入治疗的头颈部肿瘤放疗后复发患者数据,共101例,以往接受外照射中位积累剂量66 Gy。粒子植入后剂量(D90)中位数117 Gy。Kaplan-Meier法计算生存率,Logrank 检验和单因素分析,Cox模型多因素分析。结果 中位随防12.2个月。患者5年局部无进展生存率为26.6%,5年总生存率为15.5%。单因素分析显示与局控相关因素为年龄、病理类型、植入部位、病灶体积、D90、近期疗效(P均<0.05),与生存相关因素为KPS、病灶体积、D90及近期疗效(P均<0.05)。多因素分析显示病理类型、病灶体积、D90、近期疗效为与局控相关的影响因素(P=0.000、0.002、0.003、0.014)。不良反应方面,皮肤/黏膜破溃25.7%,疼痛13.9%。尚未发现不良反应与剂量的相关性。结论 125I粒子植入治疗放疗后复发头颈部肿瘤有良好的有效性及安全性,非鳞癌、病灶体积小、D90高预示较好的局控。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
吉喆
姜玉良
郭福新
彭冉
徐飞
孙海涛
范京红
李卫燕
王俊杰
关键词 头颈部肿瘤放射性粒子植入治疗结果    
AbstractObjective To evaluate the clinical efficacy and safety of CT-guided 125I seed implantation in the treatment of recurrent head and neck tumors after radiotherapy. Methods Clinical data of 101 patients who received CT-guided radioactive 125I seed implantation for recurrent head and neck cancer after radiotherapy from 2007 to 2015 were retrospectively analyzed. The median accumulated dose of external radiotherapy was 66 Gy and the median dose after seed implantation(D90) was 117 Gy. The local progression-free survival and overall survival were analyzed by Kaplan-Meier method. Univariate analysis was performed by log-rank test and multivariate analysis was conducted by using Cox regression model. Results The median follow-up time was 12.2 months. The 5-year local progression-free survival rate was 26.6%.The 5-year overall survival rate was 15.5%. Univariate analysis demonstrated that age,pathological type,implantation site,lesion volume,D90and short-term efficacy were correlated with local control,and KPS score,lesion volume,D90,and short-term efficacy were associated with survival (all P<0.05). Multivariate analysis revealed that pathological type,lesion volume,D90 and short-term efficacy were independent factors related to local control (P=0.000,0.002,0.003 and 0.014).In terms of the adverse events,skin/mucosal ulceration was observed in 25.7% and pain occurred in 13.9% of all patients. No correlation was noted between the adverse events and dose. Conclusions CT-guided radioactive 125I seed implantation is an efficacious and safe treatment of recurrent head and neck tumors after radiotherapy. Non-squamous carcinoma,small lesion volume and high dose(D90) indicate excellent local control.
Key words Head and neck neoplasm    radioactive seed implantation    Therapeutic outcome   
收稿日期: 2018-01-22     
基金资助:首都临床特色应用研究项目基金资助(Z151100004015171)
通讯作者: 王俊杰,Email:junjiewang_edu@sina.cn   
引用本文:   
吉喆,姜玉良,郭福新等. CT引导下125I粒子植入治疗放疗后复发头颈部肿瘤的临床效果[J]. 中华放射肿瘤学杂志, 2018, 27(9): 793-797.
Ji Zhe,Jiang Yuliang,Guo Fuxin et al. Clinical efficacy of CT-guided iodine-125 seed implantation for recurrent head and neck carcinoma after external beam radiotherapy[J]. Chinese Journal of Radiation Oncology, 2018, 27(9): 793-797.
链接本文:  
http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2018.09.001     或     http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2018/V27/I9/793
京公网安备11010502022167号
版权所有 © 2010《中华放射肿瘤学杂志》编辑部
地址:北京朝阳区潘学园南里17号 中国医学科学院肿瘤医院(100021)
电话:010-67700737,87788294 Email: cjron@cmaph.org
本系统由北京玛格泰克科技发展有限公司设计开发 技术支持:Support@magtech.com.cn